AJP ScaleUP

  • H.PIO stock bolstered by stock retire scheme
    H.PIO stock bolstered by stock retire scheme SEOUL, August 24 (AJP) -South Korean health supplement maker H.PIO's shares rose Monday after the company announced plans to cancel all of its treasury shares. Its shares closed 2.64 percent higher at 2,135 won ($1.54) on the KOSDAQ. The KOSDAQ-listed company said its board approved the cancellation of 191,003 common shares, according to a regulatory filing Monday. The cancellation is scheduled for Sept. 11. The cancellation represents about 0.46 percent of its 41.29 million outstanding co August 24, 2026
  • Chip equipment maker rides surprise rally in tandem with Modernas triple-digit surge
    Chip equipment maker rides surprise rally in tandem with Moderna's triple-digit surge SEOUL, August 20 (AJP) - Shares of semiconductor equipment maker N2TECH hit their daily limit on Thursday as investors rushed into related South Korean stocks following Moderna's positive results from a late-stage cancer vaccine clinical trial. N2TECH's shares closed at 1,925 won on the junior KOSDAQ, up 29.98 percent from the previous session. The stock opened at 1,831 won and fell as low as 1,646 won before rebounding to the daily limit. The rally came after U.S. biotech firm Moderna August 20, 2026
  • KOSDAQ-listed medical device maker recognized for growth potential
    KOSDAQ-listed medical device maker recognized for growth potential SEOUL, August 19 (AJP) - Medical device maker Next Biomedical has been recognized as a rising KOSDAQ-listed firm for the second year in a row, it said on Wednesday. It said it was selected for the Korea Exchange's "rising star" program again this year, which recognizes promising companies based on factors such as technology, financial health and growth potential. The firm attributed the recognition to its technology for controlling bleeding during endoscopic procedures and its gro August 19, 2026
  • Biotech firm surges after US approval of new cancer therapy
    Biotech firm surges after US approval of new cancer therapy SEOUL, August 19 (AJP) - Biotech firm Sillajen's shares surged on Wednesday, bucking a sharp market selloff, as the first U.S. approval of an oncolytic virus therapy in 11 years revived investor interest in companies developing similar cancer treatments. Its shares were trading 13 percent higher at 2,390 won in early afternoon trading after jumping as much as 29.79 percent to an intraday high of 2,745 won. The gain came despite a broad market selloff, with the benchmark KOSPI down more than August 19, 2026
  • Vascular disease biotech firm makes strong KOSDAQ debut
    Vascular disease biotech firm makes strong KOSDAQ debut SEOUL, August 18 (AJP) - South Korean biotech firm Ingenia Therapeutics made its KOSDAQ debut on Tuesday. Its shares closed at 17,990 won (US$12.70) on their first day of trading, up 49.92 percent from the offering price of 12,000 won. The strong debut may have been supported by the firm's plans to develop more drugs and pursue additional global licensing deals. It develops treatments aimed at restoring damaged small blood vessels by modifying signals in the cells that form their inner wal August 18, 2026
  • Satellite antenna maker jumps 41% in KOSDAQ debut
    Satellite antenna maker jumps 41% in KOSDAQ debut SEOUL, August 13 (AJP) — Shares of South Korean satellite communications equipment maker KNS Inc. surged on their KOSDAQ debut Thursday, trading more than 40 percent above their initial public offering price. The stock was trading at 15,480 won ($10.93) as of 2:37 p.m., up 40.73 percent from its IPO price of 11,000 won. It more than doubled to an intraday high of 24,600 won before giving back some of the gains. The strong debut comes as the company expands from commercial maritime equi August 13, 2026
  • Shares of chip parts maker jump on strong Q2 earnings
    Shares of chip parts maker jump on strong Q2 earnings SEOUL, August 12 (AJP) - Shares of semiconductor parts maker Wonik QnC rose on Wednesday after it posted a more than twofold increase in second-quarter operating profit from a year earlier. Its shares closed 5.31 percent higher at 31,750 won (US$22.44). The gain came as consolidated operating profit jumped 119.1 percent from a year earlier to 30.9 billion won ($21.8 million) for the period between April and June, according to its preliminary earnings report released the same day. Revenue also August 12, 2026
  • Shares of internet infrastructure firm fall despite strong Q2 earnings
    Shares of internet infrastructure firm fall despite strong Q2 earnings SEOUL, August 12 (AJP) - Shares of KOSDAQ-listed internet service provider KINX fell on Wednesday even after it posted a more than 50 percent jump in second-quarter operating profit. Its shares closed 6.99 percent lower at 151,600 won (US$107.14). The decline came despite a 51.15 percent jump in consolidated operating profit from a year earlier to 8.82 billion won ($6.2 million) for the period between April and June, according to its preliminary earnings report released the same day. Revenue a August 12, 2026
  • EcoPro BM higher as $900 million fundraising backs nickel project
    EcoPro BM higher as $900 million fundraising backs nickel project SEOUL, August 10 (AJP) —Shares of KOSDAQ-listed battery materials maker EcoPro BM rose Monday after the company spelled out how it would use proceeds from its 1.2 trillion won ($850 million) rights offering, with nearly two-thirds earmarked for a nickel smelter project in Indonesia. As of 2:55 p.m., the stock was trading at 114,300 won ($81), up 6.82 percent, after rising as high as 115,400 won earlier in the day. According to a revised securities registration statement filed with South August 10, 2026
  • KOSDAQ-listed biotech Alteogen rallies on BlackRock stake
    KOSDAQ-listed biotech Alteogen rallies on BlackRock stake SEOUL, August 10 (AJP) — Shares of South Korean biotech firm Alteogen jumped more than 15 percent Monday after BlackRock, the world's largest asset manager, disclosed that its combined holdings in the company had crossed 5 percent. As of 11:17 a.m., Alteogen was trading at 346,500 won ($244.74), up 13.77 percent from the previous session. The rally followed a regulatory filing submitted Friday by BlackRock Fund Advisors, which showed that the firm and its affiliated entities held a c August 10, 2026